Fentanyl misuse.
Department of Medicine (Ruzycki, Yarema), University of Calgary; Section of Clinical Pharmacology and Toxicology (Yarema), Alberta Health Services; Poison and Drug Information Service (Yarema), Alberta Health Services, Calgary, Alta. sarro@ualberta.ca.
Shannon
S
Ruzycki
Department of Medicine (Ruzycki, Yarema), University of Calgary; Section of Clinical Pharmacology and Toxicology (Yarema), Alberta Health Services; Poison and Drug Information Service (Yarema), Alberta Health Services, Calgary, Alta.
Mark
M
Yarema
D000701:Analgesics, Opioid / Q000506:poisoning*; D002170:Canada / Q000453:epidemiology; D062787:Drug Overdose / Q000188:drug therapy*; D005283:Fentanyl / Q000506:poisoning*; D006801:Humans; D009270:Naloxone / Q000008:administration & dosage; D009292:Narcotic Antagonists / Q000008:administration & dosage; D009293:Opioid-Related Disorders / Q000453:epidemiology*
D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D009270:Naloxone; D005283:Fentanyl